Amneal Pharmaceuticals, Inc.
NASDAQ: AMRX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Chirag K. Patel
- Employees
- 8,300
- Headquarters
- Bridgewater, United States
- IPO year
- 2018
- Market cap
- $5.2B
- Website
- https://www.amneal.com
Loading AMRX…
Loading profile data…Frequently asked questions about AMRX
What does Amneal Pharmaceuticals, Inc. (AMRX) do?
Amneal Pharmaceuticals, Inc., operating alongside its various subsidiaries, is a diversified pharmaceutical company involved in the development, acquisition of licenses, manufacturing, marketing, and distribution of both generic and specialized medicinal products. These offerings span a multitude of delivery formats and target a wide range of th...
Where does AMRX trade?
Amneal Pharmaceuticals, Inc. (AMRX) trades on the NASDAQ Global Select.
What sector is AMRX in?
Amneal Pharmaceuticals, Inc. (AMRX) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Amneal Pharmaceuticals, Inc.?
Chirag K. Patel is the chief executive officer of Amneal Pharmaceuticals, Inc. (AMRX).
Where is Amneal Pharmaceuticals, Inc. headquartered?
Amneal Pharmaceuticals, Inc. is headquartered in United States.
Does AMRX pay a dividend?
Amneal Pharmaceuticals, Inc. (AMRX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AMRX go public?
Amneal Pharmaceuticals, Inc. (AMRX) completed its initial public offering in 2018.